Meeting
2023 ASCO Genitourinary Cancers Symposium
Neural network analysis of tumor and germline profiling to predict survival of muscle-invasive bladder cancer following radical cystectomy: An analysis of the Cancer Genome Atlas (TCGA).
Authors
Guru P. Sonpavde
AdventHealth Cancer Institute, Orlando, FL
Guru P. Sonpavde , Layne Sadler , Arvind Ravi , Amin Nassar , Seth P. Lerner , Sooryanarayana Varambally
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 546)
DOI
10.1200/JCO.2023.41.6_suppl.546
Abstract #
546
Poster Bd #
M9
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.
First Author: Shingo Hatakeyama
Poster
2023 ASCO Genitourinary Cancers Symposium
Assessing the utility of a cell-free tumor (ct)DNA assay (MSK-ACCESS) in patients (pts) with node-positive (N+) muscle-invasive bladder cancer (MIBC) undergoing neoadjuvant chemotherapy (NAC).
First Author: Andrew B Katims
Poster
2020 Genitourinary Cancers Symposium
Optimal timing of radical cystectomy after neoadjuvant chemotherapy in muscle invasive bladder cancer (MIBC).
First Author: Saurabh Parasramka
Poster
2019 Genitourinary Cancers Symposium
Cell-free DNA (cfDNA) whole genome bisulfite sequencing in patients with muscle-invasive bladder cancer patient treated with cystectomy with curative intent.
First Author: Yi-Tsung Lu